Corteva Q2 revenue misses estimates; 2026 outlook lifted

• Seed pricing and mix — Higher prices and increased out-licensing income in the Seed segment offset lower volumes, driven by demand for top technology.
• Crop protection pricing pressure — Crop Protection sales declined due to competitive pricing in Latin America and lower volumes from timing shifts, partially offset by demand for new products.
• Cost and productivity actions — Ongoing cost discipline and productivity measures contributed to margin expansion and offset volume and price pressures.

The current average analyst rating on the shares is buy, with 15 strong buy or buy recommendations, 8 hold ratings and no sell or strong sell ratings.

The average consensus recommendation for the agricultural chemicals peer group is buy.

Wall Street's median 12-month price target for Corteva Inc is $92.37, about 2% above its July 29 closing price of $90.51.

The stock recently traded at the next 12-month earnings versus a P/E of three months ago.